151 related articles for article (PubMed ID: 32419232)
1. Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.
Zhao N; Guo Y; He Y; Chen Y; Xing J
J Clin Lab Anal; 2020 Aug; 34(8):e23354. PubMed ID: 32419232
[TBL] [Abstract][Full Text] [Related]
2. Eukaryotic translation initiation factor 3B is overexpressed and correlates with deteriorated tumor features and unfavorable survival profiles in cervical cancer patients.
Zhu P; Tan Q; Jiang W; Ou Y; Xu P; Yuan L
Cancer Biomark; 2019; 26(2):123-130. PubMed ID: 31322539
[TBL] [Abstract][Full Text] [Related]
3. The expression of eukaryotic translation initiation factor 3B and its correlation with tumor characteristics as well as prognosis in non-small cell lung cancer patients: a retrospective study.
Liu C; Li X; Tian J; Zhang S; Liu Y; Zhai X; Feng Q
J BUON; 2020; 25(5):2350-2357. PubMed ID: 33277855
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
5. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R
Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
[TBL] [Abstract][Full Text] [Related]
7. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
[TBL] [Abstract][Full Text] [Related]
8. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
Yang HM; Lou G
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
[No Abstract] [Full Text] [Related]
9. Tumor Forkhead Box Q1 Is Elevated, Correlates with Increased Tumor Size, International Federation of Gynecology and Obstetrics Stage but Worse Overall Survival in Epithelial Ovarian Cancer Patients.
Wang X; Zhu X
Cancer Biother Radiopharm; 2022 Nov; 37(9):837-842. PubMed ID: 33761267
[No Abstract] [Full Text] [Related]
10. Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 cases.
Fu Y; Wang X; Pan Z; Xie X
Front Med; 2014 Mar; 8(1):91-5. PubMed ID: 24370920
[TBL] [Abstract][Full Text] [Related]
11. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
[TBL] [Abstract][Full Text] [Related]
12. Effects of EIF3B gene downregulation on apoptosis and proliferation of human ovarian cancer SKOV3 and HO-8910 cells.
Wang L; Ouyang L
Biomed Pharmacother; 2019 Jan; 109():831-837. PubMed ID: 30551537
[TBL] [Abstract][Full Text] [Related]
13. The expression of ubiquitin-conjugating enzyme E2C and KAI1 in ovarian carcinoma and their clinical significance.
Gong Y; Wang D; Lin L; Dai J; Yu L
Medicine (Baltimore); 2019 Nov; 98(46):e17896. PubMed ID: 31725636
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
[TBL] [Abstract][Full Text] [Related]
15. Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian Cancer.
Ataseven B; du Bois A; Harter P; Prader S; Grimm C; Kurzeder C; Schneider S; Heikaus S; Kahl A; Traut A; Heitz F
Int J Gynecol Cancer; 2016 Nov; 26(9):1594-1600. PubMed ID: 27654263
[TBL] [Abstract][Full Text] [Related]
16. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
[TBL] [Abstract][Full Text] [Related]
17. Circ-ITCH correlates with small tumor size, decreased FIGO stage and prolonged overall survival, and it inhibits cells proliferation while promotes cells apoptosis in epithelial ovarian cancer.
Luo L; Gao Y; Sun X
Cancer Biomark; 2018; 23(4):505-513. PubMed ID: 30347599
[TBL] [Abstract][Full Text] [Related]
18. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of eukaryotic translation initiation factor 3b inhibited proliferation and metastasis of gastric cancer.
Ma F; Li X; Ren J; Guo R; Li Y; Liu J; Sun Y; Liu Z; Jia J; Li W
Cell Death Dis; 2019 Aug; 10(9):623. PubMed ID: 31423012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]